Smart AI for early breast cancer detection

We focus on helping to improve breast cancer survival rates by detecting cancers earlier so that treatment can be more effective and less invasive.

Improving the way mammograms are read

With the latest dedicated deep learning AI algorithms for breast cancer detection, Transpara provides radiologists with clinically proven decision support tools. Transpara is trained on over 1 million trusted mammograms and can help with daily workflow and workload. To find out more, please contact us

Transpara – the world’s first dedicated breast AI decision support solution for 2D and 3D mammography.

  • Commercially available right now. It is CE marked and FDA cleared 1
  • Multiple independent peer reviewed publications demonstrating improvement in accuracy and consistency 2
  • Proven multivendor compatibility 2

NOT ALL AI IS THE SAME – FIND OUT MORE ABOUT HOW TRANSPARA CAN HELP YOU

1. FDA Clearance applies to 2D. 3D under consideration
2. Published data held on file

Trained on over 1 million images

Use Transpara to:

Focus on early detection

Identify cancers earlier

Begin patient treatment earlier to improve survival rates

Improve mammography reading accuracy

With an improvement in accuracy and reduction in false positives, Transpara aims to minimize unnecessary treatments, patient distress and associated costs

Save time by Improving efficiency

Reduce waiting times for results

Transpara starts analysing mammograms immediately, providing objective information including level of suspicion to help the clinician with diagnosis

Rationalise radiologists’ ever-increasing workload by improving productivity

Radiologists face an ever-increasing workload so there is a need to work smarter whilst maintaining the highest quality levels when interpreting images. Transpara empowers radiologists to prioritise and focus on the most suspicious cases.

The Transpara Process

The Transpara Process
Client scan

Client scan

Client undergoes mammogram

Analyse scan

Analyse scan

Transpara analyses mammogram scan

Reading with Transpara

Reading with Transpara

Radiologist reads with support from Transpara, increasing confidence in decision

Result

Make more accurate and consistent decision

Who is Transpara for?

News

Lady alt text

Article


Transpara at ECR 2020

Not all breast AI is the same, please visit us at the ScreenPoint Medical stand #112, X1 in Vienna to

Read more
This is alt text

Article


Study confirms findings of the Transpara™ by ScreenPoint Medical AI mammogram decision support system

LONDON (PRWEB) JANUARY 03, 2020 ScreenPoint Medical’s Scientists who developed the Transpara AI decision support system which helps radiologists to identify

Read more

Article


ScreenPoint Medical and Transpara featured on Dutch TV

Nico Karssemeijer, CEO and co-founder of ScreenPoint Medical has appeared on Dutch TV (RTL4) describing how breast AI works, developments

Read more

Article


The latest AI breast cancer identification system, Transpara™ 1.6 will be showcased at RSNA 2019

The most advanced version of Transpara™ from ScreenPoint Medical unleashes the power from 2D into 3D mammography: Performance is better,

Read more
This is alt text

Article


Transpara™ by ScreenPoint Medical to showcase new medical education program to demonstrate real life use of breast AI

ScreenPoint Medical launches its new medical education program with a series of workshops entitled, “The Transpara experience – true multi-vendor,

Read more
This is alt text

Article


Volpara signs distribution agreement to sell Transpara™, Screenpoint Medical’s AI solution for breast cancer detection

WELLINGTON, New Zealand, July 23, 2019 /PRNewswire/ — Volpara Solutions and ScreenPoint Medical BV today announced signature of an agreement under which Volpara will sell ScreenPoint’s Transpara™ products

Read more